Press Releases

Burnaby, British Columbia--(Newsfile Corp. - May 16, 2024) - Great Eagle Gold Corp. (CSE: GEGC) (FSE: GI8) ("Great Eagle") is pleased to announce the signing of a binding letter of intent ("LOI") with Teras Resources Inc. ("Teras") to acquire 100% of the subsurface mineral rights pertaining to a U.S. Patented Land Claim package, located in Imperial County, California, collectively known as the Cahuilla gold project. Great Eagle has agreed to pay an immediate US $50,000... (continue reading...)

Vancouver, British Columbia--(Newsfile Corp. - May 16, 2024) - BASIN URANIUM CORP. (CSE: NCLR) (CNSX: NCLR.CN) ("Basin Uranium" or the "Company") is pleased to announce it has acquired the Great Divide Basin Uranium Project (the "Project" or "GDB") located in Sweetwater County, Wyoming, USA. The Project, which was acquired through direct staking by the Company, is comprised of 104 unpatented mineral lode claims totaling approximately 1,880 acres located in south-central... (continue reading...)

Football (U.S. soccer) is the world's most popular sport, and fandom has grown 60% in the U.S. over the past decade.

The iconic football shirt connects people to the sport's unique culture, from fans to fashion enthusiasts and celebrity influencers globally.

With the largest collection of new and hard-to-find authentic football shirts available for sale in the world, and millions of items shipped across more than 100 countries, Classic Football Shirts is the category... (continue reading...)

Customers Report High Levels of Satisfaction in Partnering and Support After Sales

SAN JOSE, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) today announced it has once again received top ratings in the 2024 TechInsights Customer Satisfaction Survey, capturing the No. 1 spot on this prestigious annual survey of global semiconductor companies for the fifth consecutive year.

Advantest has been... (continue reading...)

Gosselies (Belgium), May 16, 2024 – Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, announces today it has received a notice from the European Patent Office of its intention to grant a patent for the lead asset of Bioxodes, BIOX-101 (Ir-CPI), further broadening the candidate therapy’s protection in thromboinflammation, and adding to the company’s strong... (continue reading...)